Brain Circuitry Restoration – The New Pain Relief

YOU CAN B.E.T. ON THIS

There is an epidemic of mass tragedy - it is the current opiate/opioid epidemic in the United States which claims the lives of at least 127 people every day due to narcotic overdoses. Current treatments have only proven that we must consider newer and better ways to not only detoxify individuals from prescription opioids like methadone and buprenorphine, but induce “dopamine homeostasis” as a maintenance goal free of any opiates/opioids. Thrivacin may just be that new and better solution, as it is indicated for addressing symptoms of chronic pain, is non-addictive, non-stimulatory, and promotes functional restoration and brain reward circuitry balance as a narcotic /opiate free option for chronic pain sufferers. Dr Roger Waite is the co-owner of the company “Reward Deficiency Syndrome Systems (RDSS)” which is the creator of Thrivacin. He has been a chiropractor for 32 years; he is an inventor with patents in Electrosutical medical equipment. He has been associated with Dr Kenneth Blum; the discovered of the alcoholic gene; since 1998. Dr. Waite will be discussing the benefits and future outlook for Thrivacin. Dr. Waite has been in the forefront in the development of Prescribed and Over-the-counter (OTC) Dopamine Agonist Therapies for the clinical and retail medical markets. Dr. Waite had perfected this Dopamine Business model for many years. The original “Genetic & Dopamine Agonist Therapy model” was used by Municipal/District and Federal court systems as an alternative to drug court failures for individuals. The program had a very low rate of recidivism with individuals who were genetically predisposed to addictive behaviors. This business and therapy model was the seed program for many other successful diagnostic and treatment programs along with many other peer reviewed studies. The outcomes and success of the Las Vegas “BioClarity” program was included in a NBC news special on the program. This model was later taken to be vetted within the Workers Compensation in an answer for the complex treatment problems for the “Legacy Claim” market. Dr. Waite is a recognized national expert, author and lecturer in the field of Electroceutical Medicine. He has developed a patent pending “on-demand” medical device that will excite the Dopaminergic centers of the brain. He also has a patent for another device for over-the-counter “Electrical Anesthesia.” He had co-developed in junction with the UCLA Department of Kinesiology a computer matrix model measuring the splinting patterns of 32 independent muscular groups which measures the functionality and non-functionality of the back by diagnosing spinal soft tissue injuries. Dr. Waite has published over 50 studies in the field of electroceutical and addictive medicine. For Further Insight: Websites http://thrivacin.com/ http://www.lavitards.com/